Detailed information for compound 1832438

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 426.896 | Formula: C22H23ClN4O3
  • H donors: 1 H acceptors: 2 LogP: 4.79 Rotable bonds: 6
    Rule of 5 violations (Lipinski): 1
  • SMILES: COc1ccc(cc1)c1nn(c(=O)n1c1ccc(cc1)Cl)C(=O)NC1CCCCC1
  • InChi: 1S/C22H23ClN4O3/c1-30-19-13-7-15(8-14-19)20-25-27(21(28)24-17-5-3-2-4-6-17)22(29)26(20)18-11-9-16(23)10-12-18/h7-14,17H,2-6H2,1H3,(H,24,28)
  • InChiKey: WEVOFRYSYXJTPA-UHFFFAOYSA-N  


Substructure search Similarity search

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens cannabinoid receptor 2 (macrophage) Starlite/ChEMBL References
Homo sapiens cannabinoid receptor 1 (brain) Starlite/ChEMBL References

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity
Obtained from network model

Ranking Plot

Putative Targets List

Species Potential target Raw Global Species
Mycobacterium tuberculosis Phenolpthiocerol synthesis type-I polyketide synthase PpsC 0.0052 0.4361 0.5834
Loa Loa (eye worm) hypothetical protein 0.0088 0.8643 1
Mycobacterium ulcerans fatty acid synthase Fas 0.0016 0.0042 0.0056
Loa Loa (eye worm) fatty acid synthase 0.0052 0.4277 0.4318
Mycobacterium leprae Probable multifunctional mycocerosic acid synthase membrane associated enzyme Mas 0.0056 0.4752 0.6337
Loa Loa (eye worm) AMP-binding enzyme family protein 0.0049 0.3948 0.3889
Mycobacterium ulcerans polyketide synthase Pks13 0.0078 0.7476 1
Mycobacterium ulcerans phenolpthiocerol synthesis type-I polyketide synthase PpsE 0.0035 0.2228 0.2981
Mycobacterium ulcerans polyketide synthase 0.0056 0.4752 0.6357
Mycobacterium leprae PHENOLPTHIOCEROL SYNTHESIS TYPE-I POLYKETIDE SYNTHASE PPSA 0.0052 0.4361 0.581
Loa Loa (eye worm) hypothetical protein 0.0029 0.1592 0.0823
Toxoplasma gondii type I fatty acid synthase, putative 0.0056 0.4752 1
Mycobacterium ulcerans thioesterase TesA 0.0044 0.3311 0.443
Mycobacterium tuberculosis Phenolpthiocerol synthesis type-I polyketide synthase PpsD 0.0052 0.4361 0.5834
Mycobacterium ulcerans polyketide synthase 0.0052 0.4361 0.5834
Brugia malayi Beta-ketoacyl synthase, N-terminal domain containing protein 0.0052 0.4361 0.4361
Mycobacterium tuberculosis Probable multifunctional mycocerosic acid synthase membrane-associated Mas 0.0056 0.4752 0.6357
Mycobacterium tuberculosis Probable polyketide synthase Pks1 0.0038 0.2588 0.3461
Mycobacterium ulcerans thioesterase 0.0044 0.3311 0.443
Onchocerca volvulus 0.0091 0.9025 0.9285
Mycobacterium tuberculosis Polyketide synthetase MbtC (polyketide synthase) 0.0018 0.0229 0.0306
Mycobacterium leprae Probable polyketide synthase Pks1 0.0056 0.4752 0.6337
Mycobacterium tuberculosis Probable polyketide synthase Pks5 0.0051 0.4168 0.5576
Mycobacterium leprae PHENOLPTHIOCEROL SYNTHESIS TYPE-I POLYKETIDE SYNTHASE PPSC 0.0056 0.4752 0.6337
Mycobacterium ulcerans phenolpthiocerol synthesis type-I polyketide synthase PpsD 0.0052 0.4361 0.5834
Mycobacterium ulcerans Type I modular polyketide synthase 0.0052 0.4361 0.5834
Mycobacterium ulcerans phenolpthiocerol synthesis type-I polyketide synthase PpsC 0.0056 0.4752 0.6357
Mycobacterium leprae PHENOLPTHIOCEROL SYNTHESIS TYPE-I POLYKETIDE SYNTHASE PPSD 0.0052 0.4361 0.581
Mycobacterium tuberculosis Phenolpthiocerol synthesis type-I polyketide synthase PpsA 0.0052 0.4361 0.5834
Mycobacterium tuberculosis Polyketide synthase Pks13 0.0078 0.7476 1
Mycobacterium tuberculosis Polyketide synthase Pks12 0.0056 0.4752 0.6357
Brugia malayi AMP-binding enzyme family protein 0.0049 0.3948 0.3948
Mycobacterium ulcerans multifunctional mycocerosic acid synthase membrane-associated Mas 0.0056 0.4752 0.6357
Mycobacterium leprae PHENOLPTHIOCEROL SYNTHESIS TYPE-I POLYKETIDE SYNTHASE PPSE 0.0035 0.2228 0.2941
Mycobacterium tuberculosis Probable membrane bound polyketide synthase Pks6 0.0078 0.7476 1
Mycobacterium tuberculosis Polyketide synthase Pks2 0.0051 0.4168 0.5576
Mycobacterium tuberculosis Probable polyketide synthase Pks8 0.0043 0.3214 0.4299
Mycobacterium tuberculosis Probable polyketide synthase Pks7 0.0056 0.4752 0.6357
Mycobacterium tuberculosis Phenyloxazoline synthase MbtB (phenyloxazoline synthetase) 0.0049 0.3948 0.528
Mycobacterium leprae PROBABLE THIOESTERASE TESA 0.0044 0.3311 0.4398
Toxoplasma gondii type I fatty acid synthase, putative 0.0037 0.2547 0.3708
Toxoplasma gondii beta-ketoacyl synthase, N-terminal domain-containing protein 0.0034 0.2149 0.2574
Mycobacterium leprae Polyketide synthase Pks13 0.0078 0.7476 1
Mycobacterium ulcerans phenolpthiocerol synthesis type-I polyketide synthase PpsB 0.0042 0.3131 0.4188
Mycobacterium ulcerans Type I modular polyketide synthase 0.0052 0.4361 0.5834
Mycobacterium tuberculosis Probable thioesterase TesA 0.0044 0.3311 0.443
Mycobacterium ulcerans phenolpthiocerol synthesis type-I polyketide synthase PpsA 0.0042 0.3131 0.4188
Mycobacterium tuberculosis Probable fatty acid synthase Fas (fatty acid synthetase) 0.0016 0.0042 0.0056
Mycobacterium ulcerans polyketide synthase Pks9 0.0035 0.2228 0.2981
Mycobacterium tuberculosis Probable polyketide synthase Pks9 0.003 0.1644 0.2199
Mycobacterium tuberculosis Probable polyketide synthase Pks15 0.0021 0.061 0.0817
Mycobacterium leprae PHENOLPTHIOCEROL SYNTHESIS TYPE-I POLYKETIDE SYNTHASE PPSB 0.0042 0.3131 0.4155
Onchocerca volvulus Fatty acid synthase homolog 0.0094 0.9416 1
Mycobacterium ulcerans Type I modular polyketide synthase 0.0052 0.4361 0.5834

Activities

Activity type Activity value Assay description Source Reference
IC50 (binding) = 878 nM Antagonist activity at human CB1 receptor stably expressed in CHO cells co-expressing co-expressing Ga15/16 assessed as calcium current after 45 mins by fluo-4 AM assay ChEMBL. 24445310
IC50 (binding) = 6080 nM Antagonist activity at CB2 receptor (unknown origin) stably expressed in CHO cells co-expressing co-expressing Ga15/16 assessed as calcium current after 45 mins by fluo-4 AM assay ChEMBL. 24445310
Inhibition (binding) = 96.5 % Antagonist activity at human CB1 receptor stably expressed in CHO cells co-expressing co-expressing Ga15/16 assessed as calcium current at 10 uM after 45 mins by fluo-4 AM assay relative to basal control ChEMBL. 24445310
Inhibition (binding) = 123.5 % Antagonist activity at CB2 receptor (unknown origin) stably expressed in CHO cells co-expressing co-expressing Ga15/16 assessed as calcium current at 10 uM after 45 mins by fluo-4 AM assay relative to basal control ChEMBL. 24445310

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.